Asked by Nicole Wynters on May 07, 2024
Verified
The therapeutic action of monoamine oxidase inhibitors (MAOIs) blocks neurotransmitter reuptake, causing:
A) increased concentration of neurotransmitters in the synaptic gap.
B) decreased concentration of neurotransmitters in serum.
C) destruction of receptor sites.
D) limbic system stimulation.
Monoamine Oxidase Inhibitors (MAOIs)
A class of antidepressant drugs that work by inhibiting the activity of monoamine oxidase, thereby increasing the levels of certain neurotransmitters in the brain.
Neurotransmitter Reuptake
The process by which neurotransmitters are reabsorbed by the nerve cell that released them, helping to terminate the signal between neurons.
- Understand the therapeutic actions of different classes of psychotropic drugs on mental health conditions.
Verified Answer
HS
Hassan ShehuMay 10, 2024
Final Answer :
A
Explanation :
If the reuptake of a substance is inhibited, then it accumulates in the synaptic gap and its concentration increases, permitting the ease of the transmission of impulses across the synaptic gap. Normal transmission of impulses across synaptic gaps is consistent with a normal rather than a depressed mood. The other options are not associated with blocking neurotransmitter reuptake.
Learning Objectives
- Understand the therapeutic actions of different classes of psychotropic drugs on mental health conditions.
Related questions
A Patient Is Hospitalized for Major Depressive Disorder ...
A Patient's Spouse, Who Is a Chemist, Asks a Nurse ...
On the Basis of Current Knowledge of Neurotransmitter Effects, a ...
A Patient Hospitalized with a Mood Disorder Has Aggression, Agitation ...
A Nurse Caring for a Patient Taking a Selective Serotonin ...